The Clinical Importance of White Matter Hyperintensities on Brain Magnetic Resonance Imaging: Systematic Review and Meta-Analysis by Debette, Stéphanie & Markus, H S
Boston University
OpenBU http://open.bu.edu
Department of Neurology MED: Neurology Scholarly Works
2010-7-26
The Clinical Importance of White
Matter Hyperintensities on Brain
Magnetic Resonance Imaging:
Systematic Review and
Meta-Analysis
Debette, Stéphanie, H S Markus. "The clinical importance of white matter
hyperintensities on brain magnetic resonance imaging: systematic review and
meta-analysis" BMJ: British Medical Journal 341:c3666. (2010)
https://hdl.handle.net/2144/3170
Boston University
RESEARCH
The clinical importance of white matter hyperintensities on
brain magnetic resonance imaging: systematic review and
meta-analysis
Ste´phanie Debette, neurologist and research fellow,1,2,3 H S Markus, professor of neurology1
ABSTRACT
Objectives To review the evidence for an association of
whitematter hyperintensities with risk of stroke, cognitive
decline, dementia, and death.
Design Systematic review and meta-analysis.
Data sources PubMed from 1966 to 23 November 2009.
Study selection Prospective longitudinal studies that
used magnetic resonance imaging and assessed the
impact of whitematter hyperintensities on risk of incident
stroke, cognitive decline, dementia, and death, and, for
the meta-analysis, studies that provided risk estimates
for a categorical measure of white matter
hyperintensities, assessing the impact of these lesions on
risk of stroke, dementia, and death.
Data extraction Population studied, duration of follow-
up, method used to measure white matter
hyperintensities, definition of the outcome, and measure
of the association of white matter hyperintensities with
the outcome.
Data synthesis 46 longitudinal studies evaluated the
association of white matter hyperintensities with risk of
stroke (n=12), cognitive decline (n=19), dementia (n=17),
and death (n=10). 22 studies could be included in ameta-
analysis (nine of stroke, nine of dementia, eight of death).
White matter hyperintensities were associated with an
increased risk of stroke (hazard ratio 3.3, 95% confidence
interval 2.6 to 4.4), dementia (1.9, 1.3 to 2.8), and death
(2.0, 1.6 to 2.7). An association of white matter
hyperintensities with a faster decline in global cognitive
performance, executive function, and processing speed
was also suggested.
ConclusionWhite matter hyperintensities predict an
increased risk of stroke, dementia, and death. Therefore
whitematter hyperintensities indicate an increased risk of
cerebrovascular events when identified as part of
diagnostic investigations, and support their use as an
intermediate marker in a research setting. Their discovery
should prompt detailed screening for risk factors of stroke
and dementia.
INTRODUCTION
As magnetic resonance imaging has become widely
available and brain magnetic resonance imaging is
increasingly being carried out in various clinical set-
tings, clinicians often have to deal with the incidental
discovery of white matter lesions, appearing as hyper-
intensities onT2weighted images (fig 1). In the general
population the prevalence of white matter hyperinten-
sities ranges from 11-21% in adults aged around 64 to
94% at age 82. 12 Pathological findings in regions of
white matter hyperintensity include myelin pallor, tis-
sue rarefaction associated with loss of myelin and
axons, and mild gliosis. 3 4 These lesions are located in
the deep white matter, typically sparing subcortical U-
fibres, and are often seen together with vessels affected
by small vessel disease.5 The affected vessels are pre-
sumed to induce the lesions in deep white matter
through chronic hypoperfusion of the white matter
and disruption of the blood-brain barrier, leading to
chronic leakage of plasma into the white matter. 3 6 7
White matter hyperintensities are more common and
extensive in patients with cardiovascular risk factors
and symptomatic cerebrovascular disease. 8 White
matter hyperintensities canbemeasuredquantitatively
and non-invasively on large population samples and
have been proposed as an intermediate marker,
which could be used for the identification of new risk
factors and potentially as a surrogate end point in clin-
ical trials. 9
Several studies have assessed the relation between
white matter hyperintensities and risk of stroke,
dementia, and death, with partly conflicting results.
We systematically reviewed and meta-analysed all
published longitudinal studies that tested the associa-
tion ofwhitematter hyperintensitieswith risk of stroke,
dementia, and death, both in the general population
and in a hospital based setting.
METHODS
Using predefined search termswe identified references
through searches of PubMed from 1966 to 23 Novem-
ber 2009 (see web extramethods 1).We also identified
papers by reviewing the reference lists of relevant arti-
cles.
Study selection
Studies were limited to those in adults. We included
only prospective studies with longitudinal data on the
association ofwhitematter hyperintensities with risk of
stroke, dementia, cognitive decline, and death. We
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excluded studies if they evaluated white matter lesions
only by computed tomography (because of the lower
sensitivity of this method for measuring white matter
lesions comparedwithmagnetic resonance imaging10);
carried out magnetic resonance imaging at the end of
follow-up instead of at baseline; or had a sample size of
fewer than 50 patients. For studies with more than one
publication describing results among overlapping
groups of participants andwith the sameoutcomemea-
sure, we included only the dataset with the longest fol-
low-up. If the follow-up period was identical we
included only the dataset with the largest number of
patients (see web extra methods 2).
Data extraction
From the studies we extracted data on number of par-
ticipants, general population versus high risk partici-
pants, mean age, duration of follow-up,
characteristics of magnetic resonance imaging and
definition of white matter hyperintensities, outcome
definition (all strokes versus intracerebral haemor-
rhage or ischaemic stroke; all types of dementia versus
Alzheimer’s disease, vascular dementia, mixed vascu-
lar and Alzheimer’s dementia; and neuropsychologi-
cal measurements used to assess cognitive decline),
and number of events that occurred during follow-up.
For the measure of the association between white mat-
ter hyperintensities and the outcome we recorded,
when available, hazard ratios, odds ratios, and adjust-
ment variables when applicable. Both authors extra-
cted the information from each study, resolving any
disagreements by discussion.
Variable definition
We defined studies as being in high risk populations if
they were carried out in people selected for the pre-
sence of prevalent disease such as mild cognitive
impairment, stroke, or other vascular events, or for
the presence of a high risk factor profile. (See web
extra tables 1-5 for the inclusion criteria for each
study.) Stroke was defined as an acute onset focal neu-
rological deficit of presumed vascular cause lasting at
least 24 hours or interrupted by death within 24 hours.
Web extra tables 1-5 show the number of events by
stroke type (ischaemic versus haemorrhagic), when
available. Unless specified differently (see web extra
tables 1-5) we defined dementia according to the cri-
teria of the Diagnostic and Statistical Manual of Mental
Disorders, third or fourth editions11 12; Alzheimer’s dis-
ease based on the criteria of the National Institute of
Neurological and Communicative Disorders and
Stroke and the Alzheimer’s Disease and Related Dis-
orders Association for definite, probable, or possible
Alzheimer’s disease13; and vascular dementia accord-
ing to the National Institute of Neurological Disorders
and Stroke and the Association Internationale pour la
Recherche et l’Enseignement en Neurosciences
criteria.14 Cognitive decline was defined as worsening
performance on repeated neuropsychological tests. In
the absence of consensus onwhichneuropsychological
test was themost appropriate, we did not apply restric-
tions on type of test used.Weexamined separately tests
of global cognitive function and tests assessing perfor-
mances in specific cognitive domains (see web extra
tables 1-5 for types of test used in each study).
Web extra table 6 details study quality criteria,
including loss to follow-up, surveillance carried out
for the diagnosis of incident events, description of the
definition used for these events, and event subtypes.
We also report the availability of effect estimates and
whether the analysis took into account time to event.
Statistical analyses
Cochrane RevMan version 4·2 software (www.cc-ims.
net/RevMan/current.htm) was used to carry out meta-
analysis of the outcomes dementia, stroke, and death.
Graphs were designed using the rmeta package in R
(http://cran.r-project.org/web/packages/rmeta/
index.html). We calculated pooled hazard ratios using
the random effects inverse variance method. In a few
studies only odds ratios were available despite the
longitudinal design,15-17 therefore we considered the
odds ratios as approximations of hazard ratios.18 Sig-
nificant heterogeneity was defined by a P value <0.05
or I2 >50%.We carried out meta-analysis when at least
three studies were available for the same outcome; we
included only studies that used a categorical measure
of white matter hyperintensities. When more than two
categorieswere presentwe used the hazard ratio for the
highest category compared with the lowest category.
Studies for which the association of white matter
hyperintensities with the outcome was studied solely
in a continuous fashion (per unit increase or standard
deviation increase in quantitative volumeofwhitemat-
ter hyperintensities or semiquantitative grade forwhite
matter hyperintensities) were not included in themeta-
analysis. Indeed, white matter hyperintensities were
measured on completely different scales in the various
cohorts, using either automated quantitative volume
measures or different types of visual semiquantitative
Fig 1 | White matter hyperintensities on magnetic resonance
imaging (axial fluid attenuated inversion recovery sequence)
in two 80 year old patients: (left) minor white matter
hyperintensities; (right) extensive white matter
hyperintensities predominating in periventricular region.
White matter lesions are considered present if hyperintense
on T2 weighted, fluid attenuated inversion recovery, and
proton density images, without prominent hypointensity on
T1 weighted images
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non-linear volume measures. Although a sample size
weighted meta-analysis could be done, this would not
provide a pooled effect estimate. When both adjusted
and unadjusted values were available for the hazard
ratio, we included the value adjusted for vascular risk
factors. For studies that measured deep white matter
hyperintensities and periventricular hyperintensities
separately and did not provide a global risk estimate
for white matter hyperintensities, we meta-analysed
the results for periventricular hyperintensities (see
web extra methods 3). In a secondary analysis we
reran the meta-analysis replacing the results for peri-
ventricular hyperintensities with those for deep white
matter hyperintensities. All meta-analyses were done
separately for population based studies and studies in a
high risk population, and overall.
RESULTS
The initial search identified 958 articles, of which 53
met the inclusion criteria.15-17 19-68 This included 14 stu-
dies for stroke,1516 19-30 20 for dementia,29 31-49 21 for
cognitive decline,17 22 23 29 39 46 48 50-63 and 11 for
mortality.15 16 23 25 28 29 64-68 Some studies contained data
onmore than one outcome. Because of an overlapwith
another larger study carried out in the samepopulation
on the same outcome, seven studies were excluded:
two on stroke,27 28 three on dementia,43-45 two on cogni-
tive decline,51 59 and one on mortality.28 Hence a total
of 46 studies was included in this systematic
review15-17 19-26 29-42 46-50 52-58 60-68; 12 for
stroke,15 16 19-26 29 30 17 for dementia,17 29 31-42 47-49 19 for
cognitive decline,17 22 23 29 39 46 48 50 52-58 60-63 and 10 for
mortality.15 16 23 25 29 64-68
White matter hyperintensities and incident stroke
Incident stroke overall
Sixpopulationbased studies1519-21 29 30 and six studies in
high risk populations16 22-26 examined the relation
between white matter hyperintensities and incident
stroke (see web extra table 1). All six population
based studies could be included in the meta-analysis
(fig 2), which showed a significant association of
white matter hyperintensities with risk of stroke
(hazard ratio 3.1, 95% confidence interval 2.3 to 4.1,
P<0.001). Three studies done in high risk populations
could be included in the meta-analysis (fig 2), showing
a significant association of white matter hyperintensi-
ties with the risk of stroke (7.4, 2.4 to 22.9,
P=0.001). 16 24 26 Three studies in high risk populations
could not be included in the meta-analysis, two
because white matter hyperintensities were studied
continuously only, 23 25 and a third because only intra-
cerebral haemorrhage was studied as an outcome (see
web extra table 1). 22 All three found a significant asso-
ciation of white matter hyperintensities with incident
stroke.
The meta-analysis combining the data from popula-
tion based and high risk populations yielded a signifi-
cant association of white matter hyperintensities with
incident stroke (3.5, 2.5 to 4.9, P<0.001; see web extra
fig 2).
Incident stroke types
Few data existed on the association of white matter
hyperintensities with specific stroke types (intra-
cerebral haemorrhage, ischaemic stroke). One com-
munity based study21 found a significant association
of white matter hyperintensities with incident ischae-
mic stroke; another study did not observe any associa-
tion of white matter hyperintensities with recurrent
intracerebral haemorrhage in patients with lobar hae-
morrhage (see web extra table 1).22
Progression of white matter hyperintensities and incident
stroke
Only one study assessed the relation between progres-
sion of white matter hyperintensities and incident
stroke, in 89 patients with a history of lacunar stroke,
headache, or dizziness: a significantly increased risk of
stroke was observed in patients with progression of
white matter hyperintensities after 4.3 years compared
with those with no progression.16
White matter hyperintensities and incident dementia
Incident dementia overall
Three population based studies29 31 32 and 11 studies in
high risk populations17 34-41 47 48 examined the relation
between white matter hyperintensities and incident
dementia overall (see web extra table 2). Meta-analys-
ing the three population based studies yielded a signif-
icant association of white matter hyperintensities with
the occurrence of all types of dementia (2.9, 1.3 to 6.3,
P=0.008; fig 3). 29 31 32 Six of the 11 studies done in high
risk populations could be included in the meta-
analysis, 17 37 39 41 47 48 yielding no significant association
of white matter hyperintensities with incident demen-
tia (1.4, 0.9 to 2.3, P=0.14). Four of these six studies
General population
  Wong 2002w6
  Vermeer 2003w1
  Kuller 2004w7
  Bokura 2006w2
  Debette 2009w9
  Buyck 2009w8
Test for heterogeneity: P=0.55, I2=0%
High risk population
  Yamauchi 2002w10
  Gerdes 2006w3
  Naka 2006w14
Test for heterogeneity: P=0.12, I2=53.4%
Overall
Test for heterogeneity: P=0.19, I2=28.2%
3.1 (2.3 to 4.1)
7.4 (2.4 to 22.9)
3.5 (2.5 to 4.9)
0.5 2 4 71 15 40
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 2 | Inverse variance meta-analysis of studies testing
association of white matter hyperintensities with incident
stroke
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included patients with mild cognitive
impairment37 39 41 47: meta-analysing these separately
also did not yield any significant association (1.1, 0.8
to 1.6, P=0.46; see web extra fig 2). Five studies in high
risk populations could not be included in themeta-ana-
lysis, three because white matter hyperintensities were
studied continuously only, 35 36 40 and two because the
authors reported the absence of association without
indicating numbers (see web extra table 2). 34 38 None
of them identified a significant association of white
matter hyperintensities with incident dementia. Not
all quality criteria were satisfied for several of the stu-
dies (see web extra table 6). 34 37 38 48
When combining data from population based stu-
dies and high risk populations the risk of dementia
associated with white matter hyperintensities was
increased overall (1.9, 1.3 to 2.8, P=0.002; fig 3, also
see web extra fig 3).
Incident subtypes of dementia
Three population based studies31-33 and three studies in
high risk populations41 42 49 investigated the relation
between white matter hyperintensities and incident
Alzheimer’s disease (see web extra table 2). Only
one population based study31 and two studies in high
risk populations41 49 fulfilled our predefined criteria for
meta-analysis. Meta-analysis of these yielded a signifi-
cant association of white matter hyperintensities with
the risk of Alzheimer’s disease (see web extra fig 4).
Two population based studies31 33 and one study in a
high risk population41 tested the relation between
white matter hyperintensities and incident vascular
dementia (see web extra table 2). We did not carry
out ameta-analysis as only two studies fulfilled our pre-
defined criteria for meta-analysis,31 41 but all three
studies found a significant association of white matter
hyperintensities with incident vascular dementia (see
web extra table 2).
Progression of white matter hyperintensities and incident
dementia
One study observed that increasing volume of white
matter hyperintensities during a two year follow-up
was associated with incident dementia in depressed
patients.38 Another study, in people with white matter
hyperintensities of varying degree andmild neurologi-
cal problems, found that increasing degrees of progres-
sion of white matter hyperintensities over a three year
periodwere associatedwith a higher rate of conversion
to dementia.48
White matter hyperintensities and cognitive decline
Global cognitive decline
Five population based studies assessed the relation
between volume of white matter hyperintensities and
global cognitive decline (see web extra
table 3).29 39 50 53 63 Three studies observed that white
matter hyperintensities were associated with an
increased risk of low global cognitive test scores,50 con-
version to mild cognitive impairment, or persistent
cognitive impairment at the end of follow-up.39 63 In
one study, white matter hyperintensities were asso-
ciated with an increased risk of incident amnestic
mild cognitive impairment in participants aged over
60,29 but did not predict incident mild cognitive
impairment overall. Two studies found that increasing
periventricular hyperintensities only predicted a
higher rate of annual decline in mini-mental state
examination scores,53 or of conversion to persistent
cognitive impairment.63
Eight studies carried out in high risk populations
examined the relation of white matter hyperintensities
with global cognitive decline (see web extra
table 3).17 22 23 46 48 54 55 58 Five of them found that increas-
ing baseline volume of white matter hyperintensities
was associatedwith amore noticeable decline in global
cognitive function.23 46 48 55 58 The other three studies
observed no association.17 22 54
Decline in domain specific cognitive functions
Two population based studies evaluated the relation of
volumeofwhitematter hyperintensitieswith decline in
domain specific cognitive functions52 53: one found a
significant association of periventricular hyperintensi-
ties (but not deep white matter hyperintensities) with
decline in processing speed and executive function,53
whereas the other study observed no association of
baseline burden of white matter hyperintensities with
decline in any cognitive domain.52
Four studies in high risk populations assessed the
relation between white matter hyperintensities and
decline in specific cognitive domains48 56-58: all found
an associationof baselinewhitematter hyperintensities
with more rapid change in executive function or pro-
cessing speed. In two of these studies the association
was assessed separately for periventricular
General population
  Kuller 2003w17
  Prins 2004w4
  Debette 2009w9
Test for heterogeneity: P=0.001, I2=85.1%
High risk population
  Geroldi 2006w22
  Firbank 2007w24
  Smith 2008w25
  Bombois 2008w27
  Kantarci 2009w29
  Jokinen 2009w30
Test for heterogeneity: P=0.04, I2=57.7%
Overall
Test for heterogeneity: P<0.001, I2=72.9%
2.9 (1.3 to 6.3)
1.4 (0.9 to 2.3)
1.9 (1.3 to 2.8)
0.50.2 2 31 75 10
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 3 | Inverse variance meta-analysis of studies testing
association of white matter hyperintensities with incident
dementia
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hyperintensities and deep white matter hyperintensi-
ties and was significant for periventricular hyperinten-
sities only.57 58
Progression of white matter hyperintensities and global
cognitive decline
Twopopulation based studies examined the relation of
progression of white matter hyperintensities with
decline in global cognitive functions (see web extra
table 4).60 62 Both found that increasing progression
of white matter hyperintensities was associated with a
greater deterioration in global cognitive score; in one
study this association was significant for periventricu-
lar hyperintensities only.62
Progression of white matter hyperintensities and decline in
domain specific cognitive functions
Four population based studies tested the association of
progression of white matter hyperintensities with
decline in domain specific cognitive scores (see web
extra table 4).52 60-62 One study observed a significant
association of progression of white matter hyperinten-
sitieswith decline inmemoryperformance, conceptua-
lisation, and visuopractical skills.52 The three other
studies found an association of progression of white
matter hyperintensities with a faster decline of execu-
tive functions or processing speed.60-62 In one study this
association was significant for periventricular hyperin-
tensities only.62
Two studies tested the association of progression of
white matter hyperintensities with decline in domain
specific cognitive scores in high risk populations.(see
web extra table 4).56 57 One study, in patients with vas-
cular risk and no pre-existing cognitive impairment,
found an association of progression in volume of peri-
ventricular hyperintensities with decline in executive
function.57 The other study, in patients attendingmem-
ory clinics who were already cognitively impaired,
found no association of progression of white matter
hyperintensities with memory or executive function.56
White matter hyperintensities and mortality
Four population based studies15 29 64 65 and six studies in
high risk populations16 23 25 66-68 prospectively investi-
gated the relation between white matter hyperintensi-
ties and mortality (see web extra table 5). All four
population based studies could be included in the
meta-analysis (fig 4), which showed a significant asso-
ciation of white matter hyperintensities with risk of
death (2.3, 1.9 to 2.8, P<0.001). Four studies done in
high risk populations could also be meta-analysed
(fig 4); this showed an association of white matter
hyperintensities with mortality (1.6, 1.01 to 2.7,
P=0.04). Two studies could not be included because
white matter hyperintensities were studied continu-
ously only,23 25 both found a significant association of
white matter hyperintensities with mortality (see web
extra table 5). When studies from both population
based samples and high risk populations were pooled,
white matter hyperintensities were associated with an
increased risk of death during follow-up (2.0, 1.6 to 2.7,
P<0.001; fig 4, also see web extra fig 5).
DISCUSSION
This systematic review of 46 studies, and meta-analy-
sis, provides strong evidence that white matter hyper-
intensities are an important indicator of future risk of
disease, being associated with an increased risk of
stroke, cognitive decline (especially in the executive
function and processing speed domains), dementia,
and death.
Incident stroke
White matter hyperintensities were significantly asso-
ciated with an increased risk of stroke, both in the gen-
eral population and in high risk populations with a
history of stroke or vascular disease. It could be
hypothesised that this association merely reflects the
relation of vascular risk factors with stroke. Indeed,
age and hypertension are the main predictors of
white matter hyperintensities,69 70 and other vascular
risk factors such as smoking, diabetes, and history of
vascular disease were also shown to be associated
with lesions in white matter.71 In all studies, however,
the association of white matter hyperintensities with
stroke remained significant after adjustment for vascu-
lar risk factors. Although some residual confounding
may exist, this suggests that white matter hyperintensi-
ties reflect either the overall effect of uncontrolled vas-
cular risk factors better than the mere presence or
absence of each individual factor or that other, yet
unknown, factors play a role in the association of
white matter hyperintensities with stroke.
Incident dementia and cognitive decline
White matter hyperintensities were associated with an
increased risk of dementia in the general population,
General population
  Bokura 2006w2
  Kuller 2007w56
  Ikram 2008w57
  Debette 2009w9
Test for heterogeneity: P=0.48, I2=0%
High risk population
  Yamauchi 2002w10
  Levy 2003w5
  Kerber 2006w58
  Oksala 2009w59
Test for heterogeneity: P=0.11, I2=50.5%
Overall
Test for heterogeneity: P=0.02, I2=58.4%
2.3 (1.9 to 2.8)
1.6 (1.0 to 2.7)
2.0 (1.6 to 2.7)
0.50.01 0.1 1 42 10
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 4 | Inverse variance meta-analysis of studies testing
association of white matter hyperintensities with mortality
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but not in studies on high risk populations (mainlywith
mild cognitive impairment or a history of stroke).
When subtypes of dementia were assessed, the three
studies that investigated the relation of white matter
hyperintensities with incident vascular dementia
found a significant association, both in the general
population and in patients with mild cognitive
impairment.31 33 41 Conversely, although the meta-ana-
lysis testing the relation of white matter hyperintensi-
ties with incident Alzheimer’s disease yielded an
overall significant association, this association was dri-
ven by the large population based study,31 whereas the
two smaller studies on patients with mild cognitive
impairment did not identify any association.41 49
Finally, our systematic review suggests that, in most
studies looking at the association of white matter
hyperintensities with decline in cognitive perfor-
mance, white matter hyperintensities were associated
with a faster decline in global cognitive performance as
well as in executive function and processing speed.
This was true both in the general population and in
high risk patients with mild cognitive impairment,
memory problem, or cerebrovascular disease.
Various potential mechanisms could account for the
association of white matter hyperintensities with
dementia. Firstly, subcortical neural networks could
be damaged directly. Consistent with this hypothesis is
the predominant association with decline in executive
functions (believed to depend on cortical-subcortical
circuits passing through the white matter), which could
be disrupted by damage to white matter.5672 Secondly,
white matter hyperintensities could interact with patho-
logical changes related to Alzheimer’s disease and
thereby accelerate their clinical expression, or vice
versa.73 Thirdly, white matter hyperintensities could
be a confounder reflecting the association of vascular
risk factors74 or of concomitant ischaemic damage to
the cortex with dementia. Several studies have adjusted
for vascular risk factors, for prevalent or incident stroke,
or for concomitantmagnetic resonance imagingdefined
brain infarcts, and found similar results,293132 suggesting
that vascular risk factors are unlikely to be a major
mechanism, although undetected cortical microinfarcts
cannot be excluded.75 Finally, reverse causation
through amyloid angiopathy or wallerian degeneration
as a result of cortical atrophy has been hypothesised.7677
However, data from the Austrian Stroke Prevention
Study suggest that progression of lesions inwhitematter
precedes loss in parenchymal volume in elderly people
without dementia, implying that this reverse causation
is unlikely to play a predominant role.52
The finding that white matter hyperintensities were
associated with an increased risk of dementia and Alz-
heimer’s diseasemainly in healthypopulations andnot
in high risk patients who are already cognitively
impaired, needs to be interpreted cautiously. Studies
in high risk populations were carried out in small sam-
ples and had severalmethodological flaws. If this lesser
association in higher risk and cognitively impaired
populations is confirmed, however, it could suggest
that once the neurodegenerative lesions become
clinically evident, the effect of white matter lesions
may be less important.78 As has been suggested by
others, the presence of white matter hyperintensities
may increase the risk that an individual will develop
mild cognitive impairment or have declining perfor-
mances on cognitive tests but may not be enough to
facilitate progression from mild cognitive impairment
to dementia, the latter being overwhelmingly driven
by neurodegenerative lesions.36 41 47 An exception
could be the rare cases of pure vascular dementia,
where diffuse white matter hyperintensities could be
important also at later stages of cognitive decline and
conversion.41
Mortality
White matter hyperintensities were significantly asso-
ciated with an increased risk of death both in the gen-
eral population and in high risk populations with a
history of stroke, depression, or minor neurological
symptoms. This association could be mediated by an
increased risk of stroke and dementia. However, both
in the Rotterdam and the Framingham Offspring
Study the association of white matter hyperintensities
with mortality did not disappear after accounting for
incident dementia or stroke.29 65 The association was
more noticeable for cardiovascular mortality,2965 67
which could reflect that white matter hyperintensities
are a surrogate for an important burden of vascular risk
factors and a marker of diffuse vascular damage invol-
ving not only the arteries supplying the brain but also
peripheral and coronary arteries.24 79
Effect of progression of white matter hyperintensities
Only three studies have assessed the impact of progres-
sion ofwhitematter hyperintensities on incident stroke
and dementia, suggesting a significant association of
increasingprogressionofwhitematter hyperintensities
with these outcomes.16 38 48 Progression of white matter
hyperintensities has been more widely studied in asso-
ciation with cognitive decline, with increasing progres-
sionpredicting amore rapiddecline in global cognitive
performance and executive function.52 56 57 60-62
Limitations of the review
Although we corrected for statistical heterogeneity in
the meta-analyses, the measurement and analysis of
white matter hyperintensities varied substantially (see
web extra tables 1-5). One important source of hetero-
geneity was the automated quantitative versus visual
semiquantitative measurement of white matter hyper-
intensity volume, although visual semiquantitative
scales were shown to correlate well with volumetric
measures.80 Furthermore, total intracranial volume
was unequally included in the analyses to account for
differences in head size, and not all studies explicitly
distinguished white matter hyperintensities from lacu-
nar infarcts. Consensus recommendations on the mea-
surement of white matter hyperintensities and their
progression, as have been published for instance for
carotid intima-media thickness,81 would be useful to
improve the comparability of future studies. Another
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limitation is that some studies could not be included in
the meta-analysis because white matter hyperintensity
was studied only as a continuous variable using differ-
ent scales. All the results, including those that were not
incorporated in the meta-analysis, are available in web
extra tables 1-5. The pooled hazard ratios for dichoto-
mous measures of burden of white matter hyperinten-
sities also need to be interpretedwith caution, given the
heterogeneous definitions of thesemeasures across stu-
dies. They should therefore not be extrapolated to esti-
mate the individual risk of stroke, dementia, or death in
a patient with white matter hyperintensities on mag-
netic resonance imaging. To be as comprehensive as
possible in this review we included studies using differ-
ent tests or criteria for the diagnosis of cognitive decline
and dementia, which is an additional source of hetero-
geneity. Finally, given the strongassociationof vascular
risk factors both with burden of white matter hyperin-
tensities and with the clinical outcomes we studied, it
would be interesting to assess the modifying effect of
these risk factors on the associations we reported. This
was not feasible in the present paper, however, as the
nature anddefinitionof vascular risk factors included in
the analyses varied substantially across studies.
Implications of the review
The findings of this review have several implications.
For the clinician, they emphasise the clinical impor-
tance of white matter hyperintensities, even when
these are found as incidental findings onbrain imaging.
In such cases doctors might consider detailed screen-
ing for risk factors for stroke and dementia, even
though the benefit of doing so is not formally proved.
Although data showing that treatment of risk factors
reduces the progression of white matter hyperintensi-
ties are limited, more aggressive antihypertensive
treatment was associated with reduced progression in
patients after stroke, as well as with a reduction in
stroke itself.82
In terms of research, white matter hyperintensities
could constitute a potentially useful intermediate mar-
ker for the identification of new risk factors for stroke
and dementia. Indeed, besides being strongly asso-
ciated with the risk of stroke and dementia, white mat-
ter hyperintensities can be quantified reliably and non-
invasively on large samples and can be measured as a
continuous trait, thus providing increased statistical
power to detect an association. White matter hyperin-
tensities could prove particularly interesting for the
identification of novel genetic risk factors, as their her-
itability was shown to be as high as 55-73%.83 84
White matter hyperintensities may also have a role
as a surrogate marker to assess treatment efficacy.
Despite the importance of treatment, few have been
shown to be specifically effective in the small vessel
disease subtype of stroke. Treatment trials for small
vessel disease face major challenges, including rela-
tively slow progression of the disease necessitating
large patient populations.85 Neuropathological studies
have shown that white matter hyperintensities usually
represent pathological small vessel disease,3 5 therefore
whitematter lesionsmay be useful to screen treatments
before evaluation inmuch larger clinical studies, using
stroke and dementia as clinical end points.9 The Eur-
opean Task Force on Age-Related White Matter
Changes estimated that 195 people with confluent
lesions would be required per treatment arm to show
a 20% reduction in the rate of disease progression over
three years.9 Criteria have been proposed for the use of
imaging markers as surrogate markers for treatment
trials.86 The first criterion was that the marker must
be able to predict the natural course of the disease
and should correlate with relevant clinical features in
both cross sectional and longitudinal studies. Our
meta-analysis provides strong evidence that this
applies to white matter hyperintensities. A second cri-
terionwas that therapeutic interventions candelay pro-
gression of surrogate markers and that this correlates
with reduced occurrence of clinical end points. Sup-
port for this is available from the magnetic resonance
imaging substudy of the Perindopril Protection against
Recurrent Stroke Study, which revealed a less notice-
able progression of white matter hyperintensities with
aggressive antihypertensive treatment, particularly in
the subgroup of patients with a higher volume of white
matter hyperintensities at study entry82; an effect on
clinical end points (stroke and cognitive decline) was
also found in the main study.87
Conclusions
In conclusion, our systematic reviewandmeta-analysis
provides strong evidence thatwhitematter hyperinten-
sities predict the risk of stroke, dementia, and mortal-
ity. This emphasises that white matter hyperintensities
indicate increased cerebrovascular risk when identi-
fied clinically as part of diagnostic investigations and
supports their use as an intermediate marker in a
research setting. Further studies assessing the impact
of progression of white matter hyperintensities on
stroke and dementia are needed to help design thera-
peutic trials incorporating progression of white matter
hyperintensities as an intermediate end point.
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